Archived Story

Senior FDA career executives pledge science and evidence-based decision making in Covid pandemic era

primary article image

PermaLink

Dr. Janet Woodcock

USA Today

Related: @SteveFDA

Top News

Maryland-based biotech company Novavax starts phase 3 COVID-19 vaccine clinical trial of 10,000 participants in UK

primary article image

PermaLink

Reuters Staff

Reuters

Related: Seeking Alpha

HHS Sec Azar: AstraZeneca phase 3 Covid-19 vaccine clinical trial still on hold in the US as FDA seeks "answers to important questions to verify safety information" - CNBC

primary article image

PermaLink

Noah Higgins-Dunn

CNBC


Johnson & Johnson starts its vast 60,000 people phase 3 Covid-19 vaccine clinical trial, 2 months ahead of initial plan. Participants will be recruited from 250 sites in US, Argentina, Brazil, Chile, Colombia, Mexico, Peru and South Africa

primary article image

PermaLink

Daniella Genovese

Fox Business

Related: @NIHDirector, ClinicalTrials.gov, Wall Street Journal, New York Times

FDA reportedly to tighten Cvoid vaccine approval requirement

primary article image

PermaLink

Tim O'Donnell

yahoo

Related: Wall Street Journal, Fierce Biotech

Boris Johnson: UK at a ‘perilous turning point.’ New Covid restrictions could last six months

primary article image

PermaLink

Staff Writer

BBC


WHO unveils global plan "COVAX Facility," aiming for fairly distributing COVID-19 vaccine to the world in a staged manner, with absence of US, Russia, and China

primary article image

PermaLink

Kai Kupferschmidt

Science

Related: @GaviSeth, World Health Organization, STAT

European countries observing a second wave of Covid-19 surge, with Croatia reportedly the case study of how international travel accelerates the pandemic

primary article image

PermaLink

Bojan Pancevski

Wall Street Journal

Related: DW.COM, CNBC, CNN

Israel imposes a 2nd nationwide lockdown as Covid-19 cases re-surge

primary article image

PermaLink

Deutsche Welle

DW.COM

Related: The Jerusalem Post | JPost.com, The Hill, TIME (US magazine)

Eli Lilly antibody drug found reducing hospitalization rate in coronavirus patients from early analysis of a phase 2 clinical trial

primary article image

PermaLink

Gina Kolata

New York Times

Related: Wall Street Journal, Reuters, CNBC, STAT

China's Covid-19 vaccine approved in UAE, with 31K volunteers participated in ongoing phase 3 clinical trials and no unexpected side effects detected. China official: vaccine may be ready for public by November

primary article image

PermaLink

Natasha Turak

CNBC

Related: @hend_mana, Wall Street Journal, yahoo, South China Morning Post, The Jerusalem Post | JPost.com

While UK allowed the Oxford-AstraZeneca vaccine trial to resume, US FDA & NIH remain highly concerned on the spinal cord damage case and continue investigating

primary article image

PermaLink

Arthur Allen

The Daily Beast

Related: Reuters

Ex-FDA Commissioners describe staged market entry for Covid-19 vaccine to balance risk-benefit vs. sufficiency of data of efficacy and safety in different populations

primary article image

PermaLink

Scott Gottlieb

Wall Street Journal

Related: @ScottGottliebMD, @FaceTheNation

Israel starts a 2nd nationwide lockdown with severe restrictions due to Covid-19

primary article image

PermaLink

Oren Liebermann

CNN

Related: New York Times

'Rule of six' - UK bans social gathering of more than six people in light of new surge of Covid-19 cases. Residents urged to report breaches

primary article image

PermaLink

Staff Writer

MHRA (UK gov)

Related: huffingtonpost, BBC, The Guardian

Pfizer, BioNTech propose to FDA to increase Covid-19 vaccine clinical trial from 30K participants to 44K, so as to increase trial population diversity, to include adolescents 16 years of age, patients of HIV, Hepatitis C or B

primary article image

PermaLink

Matthew Herper

STAT

Related: BusinessWire

Oxford & AstraZeneca resume the UK part of the Covid-19 vaccine clinical trial. Clinical trials in other countries still on-hold

primary article image

PermaLink

Associated Press

Fox Business

Related: AstraZeneca, CNBC

Merck, late joining the race, starts phase 1/2 clinical trial in Belgium for its Covid-19 vaccine candidate. The Study projected to complete by April 26, 2022, with the goal of a single-dose vaccine

primary article image

PermaLink

Jared S. Hopkins

Wall Street Journal

Related: ClinicalTrials.gov

U.S. hospitals turn down 1/3 of offered remdesivir, limit its use to sickest COVID-19 patients, indicating the shortage of this drug seemingly over

primary article image

PermaLink

Deena Beasley

Reuters


FDA Commissioner Dr. Stephen Hahn interviewed by David Rubenstein at The Economic Club of Washington DC: FDA are "not going to cut corners regarding decisions on potential vaccines. It will be based on science & data"

primary article image

PermaLink

The Economic Club of Washington, D.C.

YouTube

Related: @SteveFDA, Bloomberg, CNBC

China pharma companies allowed to administer experimental Covid-19 vaccines to hundreds of thousands of people outside of clinical trials under emergency-use condition. Experts warn dangers. A company starts testing nasal spray vaccine

primary article image

PermaLink

Chao Deng

Wall Street Journal

Related: New York Times, Bloomberg, The Africa Report.com

Latest News

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

24 Sep 2020, 8:52 PM, Staff Writer, Seeking Alpha


Novavax starts late-stage COVID-19 vaccine trial in UK

24 Sep 2020, 8:25 PM, Reuters Staff, Reuters


Draft Guidelines Say Covid-19 Vaccine to Require Strict Review for Authorization

23 Sep 2020, 2:15 PM, Thomas M. Burton, Wall Street Journal


FDA to set high bar for emergency COVID-19 vaccine approvals

23 Sep 2020, 1:53 PM, Nick Paul Taylor, Fierce Biotech


A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

23 Sep 2020, 1:42 PM, Staff Writer, ClinicalTrials.gov


Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine

23 Sep 2020, 1:05 PM, Peter Loftus, Wall Street Journal


Johnson & Johnson's COVID-19 candidate enters third trial phase

23 Sep 2020, 12:46 PM, Daniella Genovese, Fox Business


AstraZeneca coronavirus vaccine trials remains on hold in the U.S., HHS chief Azar says

23 Sep 2020, Noah Higgins-Dunn, CNBC


Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine

23 Sep 2020, Carl Zimmer, New York Times


The FDA is reportedly about to make approving a coronavirus vaccine before the election a lot tougher

22 Sep 2020, 8:26 PM, Tim O'Donnell, yahoo


Coronavirus: 'We've reached a perilous turning point', says Boris Johnson

22 Sep 2020, 12:53 PM, Staff Writer, BBC


Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility

21 Sep 2020, 11:36 PM, Staff Writer, World Health Organization


WHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await

21 Sep 2020, 7:25 PM, Kai Kupferschmidt, Science


Coronavirus: Can European countries avoid a second lockdown?

21 Sep 2020, 1:28 PM, Deutsche Welle, DW.COM


Tourists in Croatia Help Feed Covid-19 Surge Across Europe

21 Sep 2020, 1:23 PM, Bojan Pancevski, Wall Street Journal


More restrictions expected in Europe as coronavirus spreads rapidly and rattles markets

21 Sep 2020, Holly Ellyatt, CNBC


64 wealthy nations, minus the U.S., China, back Covid-19 vaccine initiative

21 Sep 2020, Helen Branswell, STAT


How it all went wrong (again) in Europe as second wave grips continent

20 Sep 2020, Emma Reynolds, CNN


Nation locks down as PM threatens more restrictions

18 Sep 2020, 1:06 PM, Staff Writer, The Jerusalem Post | JPost.com


Israel's second coronavirus lockdown sows division

18 Sep 2020, 1:04 PM, Deutsche Welle, DW.COM